Nevro Corp (NVRO)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Rami Elghandour
Employees:
804
1800 BRIDGE PARKWAY, REDWOOD CITY, CA 94065
650-251-0005

Nevro Corp. engages in the development and manufacture of medical devices. The company develops and commercializes neuromodulation platform for the treatment of chronic pain. It offers a spinal cord stimulation system under the Senza, HF10, and Nevro brands. The company was founded in March 2006 and is headquartered in Redwood City, CA.

Data derived from most recent annual or quarterly report
Market Cap 1.567 Billion Shares Outstanding35.049 Million Avg 30-day Volume 718.714 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.47
Price to Revenue6.6049 Debt to Equity0.7736 EBITDA-101.671 Million
Price to Book Value10.6096 Operating Margin-31.3855 Enterprise Value2.413 Billion
Current Ratio6.973 EPS Growth-0.535 Quick Ratio5.499
1 Yr BETA 1.5057 52-week High/Low 182.45 / 41.74 Profit Margin-35.2528
Operating Cash Flow Growth-12611.022 Altman Z-Score4.4568 Free Cash Flow to Firm -82.726 Million
View SEC Filings from NVRO instead.

View recent insider trading info

Funds Holding NVRO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NVRO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

2.3 Thousand total shares from 1 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RASHID KASHIF GENERAL COUNSEL

  • Officer
53,526 2022-05-09 8

GROSSMAN D KEITH CHAIRMAN, PRESIDENT & CEO

  • Officer
  • Director
227,308 2022-04-11 11

DEMANE MICHAEL F

  • Director
370,399 2022-03-31 6

WEATHERMAN ELIZABETH H

  • Director
38,845 2022-03-31 7

FISCHER FRANK M

  • Director
41,499 2022-03-31 5

KOSARAJU SRIDHAR

  • Director
2,818 2022-03-31 4

PELLEGRINI NIAMH LOUISE CHIEF COMMERCIAL OFFICER

  • Officer
58,890 2022-03-02 3

MACLEOD RODERICK H. CHIEF FINANCIAL OFFICER

  • Officer
36,144 2022-03-02 3

OBOYLE KEVIN C

  • Director
13,318 2021-12-14 2

PRANGE KAREN

  • Director
3,870 2021-05-25 1

VALE BRAD

  • Director
8,198 2021-05-25 1

MCCORMICK SHAWN

  • Director
8,457 2021-05-24 1

SIEGEL SUSAN E

  • Director
1,883 2020-12-02 0

GALLIGAN ANDREW H CHIEF FINANCIAL OFFICER

  • Officer
59,179 2020-06-04 0

JAEGER WILFRED E

  • Director
41,145 2020-05-21 0

SCHMITZ PATRICK VICE PRESIDENT, OPERATIONS

  • Officer
18,658 2020-02-28 0

ALLEAVITCH DOUG VP, QUALITY

  • Officer
25,590 2019-11-25 0

CHRISTOFOROU CHRISTOFER VP, RESEARCH & DEVELOPMENT

  • Officer
19,570 2019-11-01 0

CARTER MICHAEL COLLIER VICE PRESIDENT, SALES

  • Officer
39,350 2019-02-20 0

ELGHANDOUR RAMI PRESIDENT & CEO

  • Officer
  • Director
122,387 2019-01-03 0

EARNHARDT LISA D

  • Director
5,303 2018-05-21 0

BEHBAHANI ALI

  • Director
5,390 2018-05-21 0

ALECXIH JAMES VICE PRESIDENT, SALES

  • Officer
0 2017-12-12 0

ENXING MICHAEL VP OF SALES

  • Officer
40,463 2017-04-04 0

WALKER ANDRE SENIOR VP,RESEARCH&DEVELOPMENT

  • Officer
961 2016-06-08 0

JOHNSON & JOHNSON

JOHNSON & JOHNSON INNOVATION - JJDC, INC.

  • 10% Owner
No longer subject to file 2015-12-31 0

BAY CITY CAPITAL LLC

BAY CITY CAPITAL FUND IV, L.P.

BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP

BAY CITY CAPITAL MANAGEMENT IV LLC

  • FORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNER
36,403 2015-06-08 0

PLIAM NATHAN B

  • Director
1,725,379 2015-06-08 0

SHANKAR BALAKRISHNAN VP, OPERATIONS

  • Officer
0 2015-01-13 0

THREE ARCH MANAGEMENT IV, L.L.C.

THREE ARCH PARTNERS IV LP

THREE ARCH ASSOCIATES IV LP

JAEGER WILFRED E

WAN MARK A

  • Director
  • FORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNER
2,210,569 2014-11-12 0

AMV PARTNERS II LP

  • FORMER 10% BENEFICIAL OWNER
No longer subject to file 2014-11-12 0

NOVO A/S

  • 10% Owner
  • SEE REMARKS
No longer subject to file 2014-11-12 0

BISGAARD PETER

  • Director
0 2014-11-05 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

RASHID KASHIF - Officer GENERAL COUNSEL

2022-05-10 17:44:12 -0400 2022-05-09 P 2,250 $44.50 a 53,526 direct 1.5421 4.0187 10.7477 5 0.0 1

GROSSMAN D KEITH - Director - Officer CHAIRMAN, PRESIDENT & CEO

2022-04-12 17:48:09 -0400 2022-04-11 F 4,263 d 227,308 direct -2.3197 -2.0679 1.5111 5 -7.4099 3

WEATHERMAN ELIZABETH H - Director

2022-04-04 21:46:42 -0400 2022-03-31 A 273 a 38,845 direct -2.266 -2.06 -42.6806 0.0 1 -44.8951 26

KOSARAJU SRIDHAR - Director

2022-04-04 21:48:48 -0400 2022-03-31 A 190 a 2,818 direct -2.266 -2.06 -42.6806 0.0 1 -44.8951 26

DEMANE MICHAEL F - Director

2022-04-04 21:46:12 -0400 2022-03-31 A 362 a 40,147 direct -2.266 -2.06 -42.6806 0.0 1 -44.8951 26

FISCHER FRANK M - Director

2022-04-04 21:54:27 -0400 2022-03-31 A 231 a 41,499 direct -2.266 -2.06 -42.6806 0.0 1 -44.8951 26

WEATHERMAN ELIZABETH H - Director

2022-04-04 21:47:25 -0400 2022-03-31 A 273 a 38,845 direct -2.266 -2.06 -42.6806 0.0 1 -44.8951 26

GROSSMAN D KEITH - Director - Officer CHAIRMAN, PRESIDENT & CEO

2022-03-28 20:31:12 -0400 2022-03-24 F 77,734 $67.08 d 231,571 direct -0.3465 7.6358 -40.6874 7.6358 6 -40.6874 31

GROSSMAN D KEITH - Director - Officer CHAIRMAN, PRESIDENT & CEO

2022-03-28 20:31:12 -0400 2022-03-24 A 147,644 a 309,305 direct -0.3465 7.6358 -40.6874 7.6358 6 -40.6874 31

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
NEVRO CORP NVRO 2022-05-20 22:15:03 UTC 0.3817 0.4383 350000
NEVRO CORP NVRO 2022-05-20 21:45:03 UTC 0.3817 0.4383 350000
NEVRO CORP NVRO 2022-05-20 21:15:03 UTC 0.3817 0.4383 350000
NEVRO CORP NVRO 2022-05-20 20:45:03 UTC 0.3817 0.4383 350000
NEVRO CORP NVRO 2022-05-20 20:15:05 UTC 0.3817 0.4383 350000
NEVRO CORP NVRO 2022-05-20 19:45:03 UTC 0.3817 0.4383 350000
NEVRO CORP NVRO 2022-05-20 19:15:04 UTC 0.3817 0.4383 350000
NEVRO CORP NVRO 2022-05-20 18:45:03 UTC 0.3767 0.4433 350000
NEVRO CORP NVRO 2022-05-20 18:15:03 UTC 0.3767 0.4433 350000
NEVRO CORP NVRO 2022-05-20 17:45:03 UTC 0.3767 0.4433 350000
NEVRO CORP NVRO 2022-05-20 17:15:03 UTC 0.3767 0.4433 350000
NEVRO CORP NVRO 2022-05-20 16:45:04 UTC 0.3927 0.4273 350000
NEVRO CORP NVRO 2022-05-20 16:15:03 UTC 0.3927 0.4273 350000
NEVRO CORP NVRO 2022-05-20 15:45:03 UTC 0.3927 0.4273 350000
NEVRO CORP NVRO 2022-05-20 15:15:03 UTC 0.3927 0.4273 350000
NEVRO CORP NVRO 2022-05-20 14:45:03 UTC 0.466 0.354 350000
NEVRO CORP NVRO 2022-05-20 14:15:04 UTC 0.466 0.354 350000
NEVRO CORP NVRO 2022-05-20 13:45:03 UTC 0.466 0.354 350000
NEVRO CORP NVRO 2022-05-20 13:15:03 UTC 0.466 0.354 350000
NEVRO CORP NVRO 2022-05-20 12:45:03 UTC 0.466 0.354 350000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
MUTUAL FUND SERIES TRUST- Catalyst Systematic Alpha Fund NVRO -103.0 shares, $-8350.21 2021-12-31 N-PORT
Trust for Professional Managers- Convergence Long/Short Equity ETF NVRO -696.0 shares, $-49903.2 2022-02-28 N-PORT
First Trust Exchange-Traded Fund III- First Trust Long/Short Equity ETF NVRO -5261.0 shares, $-345647.7 2022-01-31 N-PORT
Columbia Funds Series Trust I- Multi-Manager Directional Alternative Strategies Fund NVRO -401.0 shares, $-26345.7 2022-01-31 N-PORT
Columbia Funds Series Trust I- Multi-Manager Directional Alternative Strategies Fund NVRO -401.0 shares, $-26345.7 2022-01-31 N-PORT
WASATCH FUNDS TRUST- Wasatch Long/Short Alpha Fund NVRO -2662.0 shares, $-192542.46 2022-03-31 N-PORT
FundVantage Trust- Gotham Hedged Plus Fund NVRO -153.0 shares, $-11066.49 2022-03-31 N-PORT

Elevate your investments